Emergent

Emergent BioSolutions is a global specialty life sciences company focused on protecting and saving lives. It develops, manufactures, and supplies products and services intended to address public health threats, including biological risks, infectious disease preparedness, and the opioid crisis. Its work supports civilian and military populations, communities, governments, and public health organizations.

The company offers commercial products for ongoing health challenges, including NARCAN Nasal Spray for opioid overdose response and CYFENDUS, an anthrax vaccine used in preparedness efforts. Emergent also specializes in medical countermeasures that support national security and public health readiness for biological threats. Through strategic partnerships, it provides in-house development and manufacturing capabilities to biopharmaceutical innovators, government agencies, and nongovernmental organizations.

Emergent’s activities extend beyond products to public health education and preparedness, including efforts to improve awareness of opioid overdose risks. The company also shares information through publications, news, and its Countermeasures podcast, which explores public health crises and bioterrorism history. Its mission is to deliver protective and life-saving solutions for people around the world.